Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory breast cancer

M J Lopez1, K A Porter

  • 1Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts, USA.

The Surgical Clinics of North America
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon source-dependent activation of herbicide-mixture degradation in a synthetic microbial community enriched from black soil.

Journal of hazardous materials·2026
Same author

Microbial community in a soilless cultivation system with organic fertilization, biofertilizers and cover crop rotation.

The Science of the total environment·2025
Same author

Corrigendum to "Aqueous compost extracts with stabilized biofertilizing microbiota promote plant root growth and drought resilience" [Sci. Total Environ. 974 (2025) 179157].

The Science of the total environment·2025
Same author

Cataloging olive oil mill wastewater sludge based on toxicological profiles and functional microbial diversity.

The Science of the total environment·2025
Same author

Aqueous compost extracts with stabilized biofertilizing microbiota promote plant root growth and drought resilience.

The Science of the total environment·2025
Same author

Changes in social inequalities in excess body weight and body dissatisfaction among adolescents in Barcelona, Spain, 2016-2021.

Public health·2024
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Multimodal therapy, including induction chemotherapy, enhances survival for inflammatory breast cancer (IBC) patients. Further research is needed to optimize treatment and improve outcomes for the majority who still succumb to the disease.

Area of Science:

  • Oncology
  • Medical Therapy
  • Clinical Research

Background:

  • Inflammatory breast cancer (IBC) presents unique challenges in treatment and prognosis.
  • Multimodal therapy, incorporating induction chemotherapy, has become a standard approach for IBC management.

Purpose of the Study:

  • To review the current standard of care for inflammatory breast cancer (IBC).
  • To highlight the limitations of current therapies and identify areas for future research.

Main Methods:

  • Review of current treatment paradigms for IBC.
  • Analysis of survival data and treatment outcomes.
  • Identification of ongoing and future research directions.

Main Results:

Related Experiment Videos

  • Multimodal therapy with induction chemotherapy has significantly improved local disease control and overall survival in IBC patients.
  • Despite improvements, over 50% of IBC patients still succumb to the disease, indicating a need for further therapeutic advancements.

    • Conclusions:

    • Current multimodal therapy represents a significant advancement in IBC treatment.
    • Future research should focus on optimizing local control, refining maintenance chemotherapy, and exploring biologic response modifiers and growth factors to further enhance patient outcomes.